Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Operating Expenses (2017 - 2025)

Historic Operating Expenses for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to $130.1 million.

  • Organogenesis Holdings' Operating Expenses rose 1946.3% to $130.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $334.1 million, marking a year-over-year decrease of 1877.12%. This contributed to the annual value of $367.6 million for FY2024, which is 1701.54% up from last year.
  • As of Q3 2025, Organogenesis Holdings' Operating Expenses stood at $130.1 million, which was up 1946.3% from $113.6 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Operating Expenses ranged from a high of $144.1 million in Q2 2024 and a low of $696000.0 during Q4 2024
  • Moreover, its 5-year median value for Operating Expenses was $81.3 million (2023), whereas its average is $83.7 million.
  • Examining YoY changes over the last 5 years, Organogenesis Holdings' Operating Expenses showed a top increase of 7737.49% in 2024 and a maximum decrease of 9904.85% in 2024.
  • Organogenesis Holdings' Operating Expenses (Quarter) stood at $75.5 million in 2021, then rose by 5.53% to $79.7 million in 2022, then fell by 8.2% to $73.2 million in 2023, then tumbled by 99.05% to $696000.0 in 2024, then soared by 18597.84% to $130.1 million in 2025.
  • Its last three reported values are $130.1 million in Q3 2025, $113.6 million for Q2 2025, and $89.7 million during Q1 2025.